KANIKA WHITE: Open Payments
NPI 1891134672 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 75 payments from 16 companies in 2025. Trend: 2023 $1,394 · 2024 $1,531 · 2025 $1,464
Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $266 |
| Novo Nordisk Inc | 14 | $215 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $207 |
| Lilly USA, LLC | 13 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $120 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| ABBVIE INC. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Amgen Inc. | 3 | $58 |
Products named: Kerendia, FARXIGA, JARDIANCE, MOUNJARO, AIRSUPRA, Ozempic, Wegovy, GEMTESA.
Industry payments across GA — which companies pay providers there.
